Treatment and Outcome of CPD-Associated Peritonitis
Author Information
Author(s): Laura Troidle, Fred Finkelstein
Primary Institution: New Haven CAPD, Renal Research Institute, New Haven, Connecticut, USA
Hypothesis
What factors contribute to the development and outcome of CPD-associated peritonitis?
Conclusion
CPD-associated peritonitis remains a significant cause of morbidity and mortality, despite advances in technology and a decrease in infection rates.
Supporting Evidence
- The incidence of CPD-associated peritonitis has decreased due to technical advances.
- Approximately 80% of patients respond to antimicrobial therapy and remain on CPD therapy.
- Gram-negative and fungal infections have worse outcomes compared to gram-positive infections.
Takeaway
CPD-associated peritonitis is a serious infection that can make patients very sick, but doctors are learning more about how to treat it better.
Methodology
The study reviews existing literature and data on CPD-associated peritonitis, focusing on incidence, risk factors, treatment protocols, and outcomes.
Potential Biases
Potential bias in reporting outcomes and treatment efficacy due to reliance on retrospective studies.
Limitations
The study relies on existing data and literature, which may not capture all variables affecting peritonitis outcomes.
Participant Demographics
The study discusses patients with end-stage renal disease (ESRD) undergoing chronic peritoneal dialysis (CPD).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website